CONGRESS|#EHA2021|Nikhil C Munshi, further added about the preparation & evaluation of efficacy and safety of cilta-cel. #mmsm, #myeloma, @harvardmed, @DanaFarber pic.twitter.com/f7cUNJuo9O

— Multiple Myeloma Hub (@MM_Hub) June 12, 2021